Medical Cannabis and Pain – The Science Behind the Stories (2017)
Dr. Mark Ware is the director of clinical research at the Alan Edwards Pain Management Unit of the McGill University Health Centre (MUHC), and the vice-chair of an important federal task force that will provide guidance to the Canadian government as it prepares to introduce legislation to legalize marijuana in spring 2017. Dr. Ware, who is also an associate professor of Family Medicine and Anesthesia at McGill University and a scientist in the Brain Repair and Integrative Neuroscience (BRaIN) Program of the Research Institute MUCH, has been studying the use, safety and effectiveness of medical cannabis for the last 16 years. He is also involved in population-based studies on the impact of pain and the evaluation of complementary therapies in pain and symptom management.
“As a physician and researcher, I am aware of the important issues that health professionals of Canada will have to consider regarding cannabis use,” says Dr. Ware. “I have a balanced view of the subject and a strong ability to communicate with a wide range of stakeholders.” Led by former cabinet minister Anne McLellan, the task force consulted across the country with experts in various fields and mad recommendations with respect to the production, distribution, retail and consumption of marijuana.
Disease Fighting Power of Plant-Food Flavonoids (2016)
Dr. Vasantha Rupasinghe is a professor at Dalhousie University and the Canada Research Chair in Fruit Bioactives and Bioproducts. He is also involved in the Tree Fruit Bioproduct Research Program at Dalhousie’s Agricultural Campus, a program designed to enhance the economic value of tree fruit crops and to ensure the sustainability of the tree fruit industry.
Professor Rupasinghe’s research focuses on plant compounds, particularly polyphenols which include a class of compounds called flavonoids. These chemicals are known for their anti-oxidant properties and may play an important role in disease prevention and promoting human health and wellness. In addition to his research on flavonoids, he is interested in the development and evaluation of value-added health food, natural food additives, functional foods, and natural health products.
Why We Should Be Immune to Influenza Vaccination & Mask Policies (2015)
Dr. Michael Gardam is Director of Infection Prevention and Control at the University Health Network since 2001, and the former Director of Infectious Disease Prevention and Control at Public Health Ontario (2008 – 2010). Michael has worked to prevent the spread of infectious diseases in healthcare settings and the community. He is currently Physician Director of Infection Prevention and Control Canada; the National Lead of infection control collaboratives for Safer Healthcare Now! and is a pioneer of using behavioural change approaches, including ‘Positive Deviance’ and ‘Front Line Ownership’ to improve patient safety.
In addition to general infectious diseases practice, Michael’s clinical work focuses on the prevention and treatment of tuberculosis and he is the founding Medical Director of the tuberculosis clinic at Toronto Western Hospital. Michael is also an Associate Professor of Medicine at the University of Toronto and has published more than 100 scientific works. Michael is a graduate of McGill University in Montréal and the University of Toronto and is a Fellow of the Royal College of Physicians and Surgeons of Canada in infectious diseases.
A Long and Healthy Working Life (2014)
Dr. Anil Adisesh JD Irving, Limited Research Chair in Occupational Medicine at Dalhousie Medicine New Brunswick, a specialist physician in occupational medicine at Horizon Health Network, and chair of the World Health Organisation (WHO) Global Working Group on Occupational Health for the Revision of the International Classification of Diseases (ICD 11). The broad theme of Dr Adisesh’s research is “Long and healthy working lives”, recognising that not only are careers sometimes curtailed through injury and illness, but that increasingly we will be working at an older age and we wish to be as healthy as possible throughout our lives.
The Impact of Sleep Deprivation on Human Performance and Emotion (2013)
Dr. Kimberly Cote is a Professor of Psychology and Neuroscience at Brock University in St. Catharines, Ontario, and the Director of the Sleep Research Laboratory at Brock University. The Sleep Research Laboratory is a 3-bedroom facility specifically designed for multiple-channel recording of EEG and event-related potentials in human sleep and wakefulness. She has published on topics such as the impact of sleep deprivation on human performance and emotion; sleep onset mechanisms in good and poor sleepers; the benefits of napping across the lifespan; the role of sleep in memory consolidation; and information processing capabilities during varying depths of sleep.
Finding Causes of Serious Mental Illness - The Saint John Study (2012)
Dr. Anne Bassett is Director of the Clinical Genetics Research Program in the Clinical Research Department and Clinician Scientist in the Campbell Family Mental Health Research Institute at CAMH. She is also a Senior Scientist at the Toronto General Research Institute, holds the Dalglish Chair at the University Health Network, and is a Professor of Psychiatry at the University of Toronto.
Dr. Bassett is an internationally renowned expert in the genetics of schizophrenia and other complex developmental disorders, including congenital cardiac disease. Dr. Bassett has pioneered studies of a molecular subtype of schizophrenia known as 22q11.2 deletion syndrome. Individuals born with a 22q11.2 deletion have a one-in-four chance of developing schizophrenia. About one out of every 100 patients with schizophrenia has a 22q11.2 deletion that may be found with a standard clinical blood test. Translating genetic research findings directly into clinical practice is an exciting area of her research that has a strong medical focus.
Making Care Better: Research Opportunities in Everyday Clinical Practice with Older Adults (2011)
Dr. Kenneth Rockwood is a Professor of Geriatric Medicine at Dalhousie University, a Canadian Institutes of Health Research Investigator and an active staff physician in the Department of Medicine at Capital Health, Halifax. As the Kathryn Allen Weldon Professor of Alzheimer Research, he has a longstanding interest in dementia and delirium.
He is also a leading authority on frailty, focusing his investigations on the complexity of frailty, and what can be termed as 'clinico-mathematical correlation'. He has published six books and more than 250 peer-reviewed scientific publications. Currently, he is co-editor of the 7th edition of Brocklehurst's Textbook of Geriatric Medicine & Gerontology. He is the principal investigator of the Research to Action Program in Dementia (RAPID), a national, multicentre project to provide better care for people with dementia by facilitating and carrying out translational research and knowledge translation.
Atlantic Partnership for Tomorrow’s Health (PATH) (2010)
Dr. Louise Parker is Professor, Departments of Medicine and Pediatrics at Dalhousie University (cross-appointed to Community Health & Epidemiology), the Canadian Cancer Society (Nova Scotia Division) Endowed Chair in Population Cancer Research, the Director of Cancer Research, Cancer Care Nova Scotia, and an affiliated Scientist, Capital Health. Dr. Parker heads the $7-million Atlantic Partnership for Tomorrow’s Health (PATH) study. PATH will recruit 30,000 volunteers from across Atlantic Canada to take part in a long-term population health study of the genetic, lifestyle and environmental factors behind the region’s high cancer rates. Findings will shed light on the causes of cancer and lead to better methods of detection, treatment and prevention.
Evidence-Informed Decision Making: Pipe-Dream or Possibility (2009)
Dr. Stephen Bornstein is a professor and the Director for the Centre of Applied Health Research, Memorial University. He is also the Founding Director of the Newfoundland Centre for Applied Health Research.